INS and early-onset autosomal dominant Alzheimer disease: Insulin resistance, a medical status in which the insulin production is sufficient but the body is failing to make use of insulin properly, is a hallmark of Alzheimer’s disease (AD), type II diabetes (T2D), and Parkinson’s disease (PD) (Cardoso and Moreira, 2020; Xi and Xu, 2021).